HR 7166 · 117th Congress
Make Medicine in America Again Act
This bill gives pharmaceutical companies significant tax breaks to encourage them to manufacture drugs and drug ingredients inside the United States. The main incentive is a tax credit worth 50 percent of what companies spend on pharmaceutical manufacturing activities here—meaning if a company spends $100 million on…
- Sponsor
- Mooney, Alexander X. (R-WV)
- Introduced
- 2022-03-18
- Policy area
- Taxation
- Latest action
- Referred to the House Committee on Ways and Means.
Digging through Congress... 🔍